Melanotan II is a synthetic peptide analog of alpha-melanocyte-stimulating hormone (α-MSH), designed for research purposes to enhance skin pigmentation, appetite control, and libido. It improves upon Melanotan I (afamelanotide) by having broader melanocortin receptor affinity, adding effects on MC3R/MC4R for appetite suppression and sexual arousal beyond just tanning and UV protection. Achieves natural-looking tans with minimal sun exposure, reduces UV damage risk, aids weight loss via hunger reduction, and boosts libido in men and women.


300.00AED 
  • Shipping: 

Learn More



WHAT IS MELANOTAN?


Melanotan is a synthetic peptide analog of the naturally occurring hormone alpha-melanocyte-stimulating hormone (α-MSH). It comes in two main forms: Melanotan I (also known as afamelanotide) and Melanotan II. Melanotan I is primarily researched for its role in stimulating melanin production to promote skin pigmentation and provide photoprotection. Melanotan II, the more commonly discussed variant, not only enhances tanning but also influences appetite and sexual function through its action on melanocortin receptors. These peptides are not FDA-approved for human use and are typically available as research chemicals for investigational purposes only. Always consult a healthcare professional before considering any peptide, as they carry potential risks and are not intended for cosmetic or therapeutic applications without supervision.



HOW DOES IT WORK?


Melanotan works by binding to melanocortin receptors (primarily MC1R for tanning effects), which triggers eumelanin production in the skin. This leads to darker pigmentation even without UV exposure from the sun or tanning beds. Melanotan II additionally activates other melanocortin pathways, potentially suppressing appetite and enhancing libido by crossing the blood-brain barrier. Research suggests it may offer protective effects against UV damage by increasing melanin, which acts as a natural barrier to harmful rays.



KEY BENEFITS:


  • Tanning Without Sun Exposure: Achieves a natural-looking tan in days to weeks, reducing the need for harmful UV rays and lowering skin cancer risk through increased photoprotection.
  • Appetite Suppression: May aid in weight management by reducing hunger, particularly with Melanotan II.
  • Enhanced Libido: Melanotan II is noted for increasing sexual arousal and function in both men and women.
  • Skin Health: Could improve conditions like erythropoietic protoporphyria (EPP) in clinical settings (for Melanotan I), though this is off-label.

These benefits are derived from studies and anecdotal evidence; individual results vary, and long-term effects are not fully understood.



DOSAGE GUIDLINES


Dosages are not standardized due to the investigational nature of Melanotan. Always start low to assess tolerance, and reconstitute lyophilized powder with bacteriostatic water for subcutaneous injection. Typical protocols from research sources include:


  • Loading Phase: 0.25–0.5 mg per day for 5–10 days until desired pigmentation is achieved.
  • Maintenance Phase: 0.5–1 mg once or twice per week to sustain the tan.
  • Administration: Injected under the skin (subcutaneously) using an insulin syringe, often in the evening to minimize side effects. Cycle length is usually 4–8 weeks, followed by a break.

Adjust based on body weight (e.g., 0.01–0.02 mg/kg) and monitor for adverse reactions. Professional medical guidance is essential, as improper use can lead to uneven pigmentation or other issues.



POTENTIAL SIDE EFFECTS & PRECAUTIONS


  • Nausea, facial flushing, and stomach cramps (often dose-dependent and subside with time).
  • Yawning, fatigue, and decreased appetite.
  • Darkening of moles, freckles, or existing pigmentation.
  • Increased libido (beneficial for some, but unexpected for others).

More serious risks involve injection-site reactions, potential kidney strain, or unknown long-term effects like melanoma risk (though some studies suggest protection). Avoid if pregnant, breastfeeding, or with a history of skin cancer.

Melanotan II (MT-II) is a synthetic tetrapeptide analogue of alpha-melanocyte-stimulating hormone (α-MSH), a natural hormone produced in the pituitary gland. Developed initially as a potential treatment for skin conditions and photoprotection against UV damage, it is now primarily used as a research-grade injectable for inducing skin tanning without extensive sun exposure. It also influences other physiological functions like libido and appetite regulation. Available in lyophilized powder form for reconstitution, Melanotan II is not approved for human therapeutic use and is classified as a research chemical.
Melanotan II mimics α-MSH by binding non-selectively to melanocortin receptors (MC1R, MC3R, MC4R, and MC5R) throughout the body. Activation of MC1R in skin melanocytes stimulates melanogenesis—the production of melanin pigment—leading to darker skin pigmentation and a tan-like appearance with minimal UV exposure. It also crosses the blood-brain barrier, influencing MC3R and MC4R in the brain for effects on sexual arousal, appetite suppression, and energy homeostasis. Compared to Melanotan I (afamelanotide), MT-II is shorter-acting but more potent, with broader receptor affinity that contributes to additional side effects.
Melanotan II promotes a sunless tan by increasing melanin production, potentially reducing UV exposure risks like sunburn and skin damage. Other reported benefits include enhanced libido and erectile function (similar to PT-141, a derivative), appetite suppression for weight management, improved metabolic regulation (e.g., fat loss and glucose control), and possible immune modulation. Users may achieve noticeable tanning effects within 5-10 doses, with animal and in vitro studies suggesting photoprotective qualities against UV-induced damage.
Start with a loading phase of 0.25-0.5 mg daily (or every other day) until the desired tan is achieved (often 1-2 weeks), then switch to maintenance dosing of 0.5-1 mg weekly or as needed. Administer in the evening to minimize nausea, and combine with brief UV exposure (sun or tanning bed) for enhanced results. Cycle for 4-8 weeks with breaks to avoid desensitization; monitor skin changes and adjust based on skin type (fairer skin may require lower doses).
Short-term side effects include facial flushing, nausea, appetite loss, spontaneous erections, yawning, and darkening of freckles/moles. Long-term risks may involve increased melanoma risk due to altered pigmentation, cardiovascular effects, or unknown impacts from unregulated use. Precautions: Avoid if pregnant, nursing, or with a history of skin cancer, heart issues, or hormone sensitivities. Start with low doses to test tolerance; monitor moles for changes and use sunscreen. Consult a healthcare provider, as quality varies and contamination is a risk with unregulated sources.
It's primarily for adults over 18 seeking cosmetic tanning, libido enhancement, or appetite control as a research supplement. Those with fair skin prone to burning, individuals in low-sun areas, or biohackers exploring metabolic benefits may find it appealing.
Yes, it pairs well with vitamin D for skin health, antioxidants like vitamin C to combat oxidative stress, or peptides like PT-141 for enhanced libido effects. Avoid combining with other tanning agents or hormones without guidance to prevent overstimulation or interactions